Pages that link to "Q71020823"

The following pages link to Peripheral blood tyrosinase messenger RNA detection and survival in malignant melanoma (Q71020823):

Displaying 37 items.

• Serial detection of circulating tumour cells by reverse transcriptase-polymerase chain reaction assays is a marker for poor outcome in patients with malignant melanoma (Q33263686) (← links)
• Melanoma. A multidisciplinary approach for the general surgeon (Q33932031) (← links)
• Molecular detection and characterisation of circulating tumour cells and micrometastases in solid tumours (Q34013815) (← links)
• Molecular characterization of minimal residual cancer cells in patients with solid tumors (Q34164586) (← links)
• New prognostic factors of cutaneous melanoma: a review of the literature. (Q34756424) (← links)
• Diagnostic accuracy of circulating tumor cells detection in gastric cancer: systematic review and meta-analysis (Q34786019) (← links)
• Molecular pathology of tumor metastasis. II. Molecular staging and differential diagnosis (Q35039979) (← links)
• An electrochemical immunosensing method for detecting melanoma cells. (Q35997850) (← links)
• Elevated pretreatment serum levels of soluble vascular cell adhesion molecule 1 and lactate dehydrogenase as predictors of survival in cutaneous metastatic malignant melanoma (Q36114813) (← links)
• Aberrant retention of tyrosinase in the endoplasmic reticulum mediates accelerated degradation of the enzyme and contributes to the dedifferentiated phenotype of amelanotic melanoma cells (Q36181464) (← links)
• Melanoma biomarkers: Vox clamantis in deserto (Review) (Q36216949) (← links)
• Elevated serum levels of S100 and survival in metastatic malignant melanoma (Q36431732) (← links)
• Reproducibility of detection of tyrosinase and MART-1 transcripts in the peripheral blood of melanoma patients: a quality control study using real-time quantitative RT-PCR (Q36617708) (← links)
• Detection of regional melanoma metastases by ultrasound B-scan, cytology or tyrosinase RT-PCR of fine-needle aspirates (Q36620517) (← links)
• Prognostic significance of the sequential detection of circulating melanoma cells by RT-PCR in high-risk melanoma patients receiving adjuvant interferon (Q36645922) (← links)
• Tyrosinase expression in the peripheral blood of stage III melanoma patients is associated with a poor prognosis: a clinical follow-up study of 110 patients (Q36671295) (← links)
• Issues affecting molecular staging in the management of patients with melanoma (Q36990701) (← links)
• The usefulness of tyrosinase in the immunohistochemical assessment of melanocytic lesions: a comparison of the novel T311 antibody (anti-tyrosinase) with S-100, HMB45, and A103 (anti-melan-A) (Q38462040) (← links)
• Quantitative nested real-time RT-PCR specific for tyrosinase transcripts to quantitate minimal residual disease (Q40754258) (← links)
• Reliability of reverse transcription-polymerase chain reaction (RT-PCR)-based assays for the detection of circulating tumour cells: a quality-assurance initiative of the EORTC Melanoma Cooperative Group (Q40845764) (← links)
• Limitations of the nested reverse transcriptase polymerase chain reaction on tyrosinase for the detection of malignant melanoma micrometastases in lymph nodes (Q40867701) (← links)
• gp100 mRNA is more sensitive than tyrosinase mRNA for RT-PCR amplification to detect circulating melanoma cells in peripheral blood of melanoma patients (Q40880269) (← links)
• Detection of circulating melanoma cells in the blood of melanoma patients: a preliminary study (Q40901882) (← links)
• Prognostic Factors in Malignant Melanoma (Q41520554) (← links)
• Limitations of cytokeratin 20 RT-PCR to detect disseminated tumour cells in blood and bone marrow of patients with colorectal cancer: expression in controls and downregulation in tumour tissue (Q42937473) (← links)
• Melanoma-inhibiting activity (MIA) mRNA is not exclusively transcribed in melanoma cells: low levels of MIA mRNA are present in various cell types and in peripheral blood (Q43201983) (← links)
• Diagnostic value and prognostic significance of protein S-100beta, melanoma-inhibitory activity, and tyrosinase/MART-1 reverse transcription-polymerase chain reaction in the follow-up of high-risk melanoma patients (Q44375017) (← links)
• RT-PCR for Tyrosinase-mRNA-Positive Cells in Peripheral Blood: Evaluation Strategy and Correlation with Known Prognostic Markers in 123 Melanoma Patients (Q50902053) (← links)
• New prognostic factors in melanoma: mRNA tumour markers. (Q52981757) (← links)
• Detection of Circulating Melanoma Cells by a Two-marker Polymerase Chain Reaction Assay in Relation to Therapy (Q54779075) (← links)
• Prognostic significance of detection of prostate-specific antigen transcripts in the peripheral blood of patients with metastatic androgen-independent prostatic carcinoma (Q60156379) (← links)
• Expression of melanoma inhibitory activity in melanoma and nonmelanoma tissue specimens (Q61829672) (← links)
• Detection of tumor cells in the portal and peripheral blood of patients with colorectal carcinoma using competitive reverse transcriptase-polymerase chain reaction (Q74555329) (← links)
• Pathologic parameters in the diagnosis and prognosis of primary cutaneous melanoma (Q77366765) (← links)
• Classification and staging of melanoma (Q77366769) (← links)
• Prognosis in malignant melanoma (Q77366773) (← links)
• Simultaneous analysis of tyrosinase mRNA and markers of tyrosinase activity in the blood of patients with metastatic melanoma (Q77787634) (← links)